Search results for "Influenza"
New year brings big, small changes to practice administration
Three federal regulations create new opportunities and hurdles for physicians, including new reimbursements, Medicare annual wellness visits and a potential uptick in office visits to document over-the-counter drugs for health plans.
https://immattersacp.org/archives/2011/02/coding.htm
1 Feb 2011
Warning about different doses for 2 forms of posaconazole
This update covers a warning that differences in dosing regimens between the 2 oral formulations of posaconazole (Noxafil) have resulted in dosing errors.
https://immattersacp.org/archives/2016/03/fda.htm
1 Mar 2016
Outgoing College leaders reflect on unprecedented year
As their terms come to a close this month, Jacqueline W. Fincher, MD, MACP, and Heather E. Gantzer, MD, MACP, ACP's President and Chair of the Board of Regents, respectively, talked to ACP Internist about the unique challenges and opportunities of 2020.
https://immattersacp.org/archives/2021/04/outgoing-college-leaders-reflect-on-unprecedented-year.htm
1 Apr 2021
Recalls: Propofol, ventilators, infusion sets, acetaminophen
A summary of approvals, recalls, warnings and alerts digested by ACP Internist from the Food and Drug Administration's alerts.
https://immattersacp.org/archives/2009/10/fda.htm
1 Oct 2009
New warnings added on multiple diabetes drugs
This update also covers a risk evaluation and mitigation strategy for liraglutide and approval of a new PCSK9 inhibitor.
https://immattersacp.org/archives/2015/11/fda.htm
1 Nov 2015
New dosing for ESAs and oseltamivir, warning on pioglitazone
Recalls, warnings, and approvals.
https://immattersacp.org/archives/2011/09/fda.htm
1 Sep 2011
Warning on medication confusion, recalls due to sterility
This update covers possible confusion between an antidepressant and an anti-clotting drug, as well as 2 sterility warnings.
https://immattersacp.org/archives/2015/10/fda.htm
1 Oct 2015
Risks of diclofenac sodium, fosamprenavir calcium detailed
Warnings, label changes, recalls, and approvals.
https://immattersacp.org/archives/2010/02/fda.htm
1 Feb 2010
First device approved to treat congenital heart disease
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2021/05/first-device-approved-to-treat-congenital-heart-disease.htm
1 May 2021
Ketorolac, Liposyn recalled for particulate contamination
A summary of approvals, recalls, warnings and alerts digested by ACP Internist from the Food and Drug Administration's alerts.
https://immattersacp.org/archives/2010/01/fda.htm
1 Jan 2010